Summary
Since proteolysis of the dermal collagenous matrix and basement membranes is required for local invasive growth and early metastasis formation of cutaneous melanomas, we have analysed the activities/expression levels of certain metalloproteinases in melanomas and cultured melanoma cells by in situ hybridization and Northern analysis. In addition to collagenases-1 and -3 that have been implicated in invasive growth behaviour of various malignant tumours, we analysed the levels of 72-kDa gelatinase and its activators MT1-MMP and TIMP-2 in cultured melanoma cells. The lesions examined included three cases of lentigo maligna and 28 cases of Clark grade I–V melanomas. The premalignant as well as the grade I tumours were consistently negative for collagenase-1 and -3 and TIMP-1 and -3. The collagenases were predominantly expressed in the cancer cells of Clark grade III and IV tumours. TIMP-1 and -3 were abundantly expressed in the cancer and/or stromal cells of grade III and IV melanomas, while TIMP-2 protein was detected also in melanomas representing lower invasive potential. Northern analysis of seven melanoma cell lines showed that the expression of collagenase-1 and TIMPs-1 and -3 was associated with 72-kDa gelatinase positivity. All melanoma cell lines were positive for MTI-MMP and TIMP-2 mRNAs. Our results suggest that overexpression of collagenases-1 and -3 and TIMPs -1 and -3 is induced during melanoma progression. Expression of TIMPs may reflect host response to tumour invasion in an effort to control MMP activity and preserve extracellular matrix integrity.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahonen, M., Baker, A. H. & Kähäri, V-M (1998). Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells. Cancer Res 58: 2310–2315.
Airola, K., Johansson, N., Kariniemi, A-L, Kähäri, V-M & Saarialho-Kere, U. K. (1997). Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 109: 225–231.
Airola, K., Ahonen, M., Johansson, N., Heikkilä, P., Kere, J., Kähäri, V-M & Saarialho-Kere, U. K. (1998). Human TIMP-3 in expressed during fetal development, hair growth cycle and cancer progression. J Histochem Cytochem 46: 437–448.
Anand-Apte, B., Bao, L., Smith, R., Iwata, K., Olsen, B. R., Zetter, B. & Apte, S. S. (1996). A review of tissue inhibitor metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth. Biochem Cell Biol 74: 853–862.
Anand-Apte, B., Pepper, M. S., Voest, E., Montesano, R., Olsen, B., Murphy, G., Apte, S. S. & Zetter, B. (1997). Inhibition of angiogenesis by tissue inhibitor metalloproteinase-3. Invest Ophthal Visual Sci 38: 817–823.
Birkedal-Hansen, H., Moore, W. G. I., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A. & Engler, J. A. (1993). Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4: 197–250.
Breslow, A. (1970). Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg 172: 902–908.
Brooks, P. C., Strömblad, S., Sanders, L. C., von, Schalscha TL, Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P. & Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 85: 683–693.
Brown, P. D., Levy, A. T., Margulies, I. M. K., Liotta, L. A. & Stetler-Stevenson, W. G. (1990). Independent expression and cellular processing of Mr 72 000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 50: 6184–6191.
Butler, G., Butler, M. J., Atkinson, S. J., Will, H., Tamura, T., Schade van Westrum, S., Crabbe, T., Clements, J., d’Ortho, M-P & Murphy, G. (1998). The TIMP-2 membrane type 1 metalloproteinase ‘receptor’ regulates the concentration and efficient activation of progelatinase A. J Biol Chem 273: 871–880.
Chomczynski, P. & Sacchi, N. (1987). Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159.
Clark, W. H. Jr, From, L. & Bernardino, E. H. (1969). Histogenesis and biologic behavior of primary human malignant melanoma of the skin. Cancer Res 29: 705–727.
Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Selzer, J. L., Kronberger, A., He, C., Bauer, E. A. & Goldberg, G. I. (1988). H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263: 6579–6587.
Deryugina, E., Luo, G-X, Reisfeld, R. A., Bourdon, M. A. & Strongin, A. (1997). Tumor cell invasion through Matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 17: 3201–3210.
Durko, M., Navab, R., Shibata, H. R. & Brodt, P. (1997). Suppression of basement membrane type IV collagen degradation and cell invasion in human melanoma cells expressing an antisense RNA for MMP-1. Biochim Biophys Acta 1356: 271–280.
Fong, K. W., Kida, Y., Zimmerman, P. V. & Smith, P. J. (1996). TIMP-1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res 2: 1369–1372.
Forth, P., Marty, L., Piechaczyk, M., El Sabrouty, S., Dani, C., Jeanteur, P. & Blanchard, J. M. (1985). Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 13: 1431–1422.
Freije, J. M. P., Díez-Itza, I., Balbín, M., Sánchez, M., Blasco, R., Tolivia, J. & López-Otín, C. (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269: 16766–16733.
Gomez, D. E., Alonso, D. F., Yoshiji, H. & Thorgeirsson, U. P. (1997). Tissue inhibitors of MMPs: structure, regulation and biological functions. Eur J Cell Biol 74: 111–122.
Herlyn, B., Balaban, G., Bennicelli, J., DuPont, I. V. G., Halaban, R., Herlyn, D., Elder, D. E., Maul, G. G., Steplewski, Z., Nowell, P. C., Clark, W. H. & Koprowski, H. (1985a). Primary melanoma cells of the vertical growth phase: similarities to metastatic cells. J Natl Cancer Inst 74: 283–239.
Herlyn, M., Thurin, J., Balaban, G., Bennicelli, J., Herlyn, D., Elder, D. E., Bondi, E., Guerry, D., Nowell, P., Clark, W. H. & Koprowski, H. (1985b). Characteristics of cultured human melanocytes isolated from different stages of tumor progression. Cancer Res 45: 5670–5676.
Höyhtyä, M., Hujanen, E., Turpeenniemi-Hujanen, T., Thorgeirsson, U., Liotta, L. A. & Tryggvason, K. (1990). Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type-IV collagenase. Int J Cancer 46: 282–286.
Iliopoulos, D., Ernst, C., Steplewski, Z., Jambrosic, J. A., Rodeck, U., Herlyn, M., Clark, W. H., Koprowski, H. & Herlyn, D. (1989). Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosides. J Natl Cancer Inst 81: 440–444.
Johansson, N., Airola, K., Greman, R., Kariniemi, A-L, Saarialho-Kere, U. & Kähäri, V-M (1997). Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 151: 499–508.
Johnson, M. D., Choi Kim, H-R, Chesler, L., Tsao-Wu, G., Bouck, N. & Polverini, P. J. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. J Cell Physiol 160: 194–202.
Kähäri, V-M & Saarialho-Kere, U. (1997). Matrix metalloproteinases in skin. Exp Dermatol 6: 199–213.
Khokha, R. (1994). Suppression of the tumorigenic and metastatic abilities of murine B16-F10 melanoma cells in vivo by the overexpression of the tissue inhibitor of metalloproteinases-1. J Natl Cancer Inst 86: 299–304.
Knäuper, V., López-Otín, C., Smith, B., Knight, G. & Murphy, G. (1996). Biochemical characterization of human collagenase-3. J Biol Chem 271: 1544–1550.
Knäuper, V., Cowell, S., Smith, B., Lopez-Otin, C., O’Shea, M., Morris, H., Zardi, L. & Murphy, G. (1997). The role of C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 272: 7608–7616.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227: 680–685.
Lehti, K., Lohi, J., Valtanen, H. & Keski-Oja, J. (1998). Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface. Biochem J 334: 345–353.
Lever, W. F. & Schaumburg-Lever, G. (1990). Benign melanocytic tumors and malignant melanoma. In Histopathology of the Skin, Lever WF and Schaumburg-Lever G (eds), pp. 756–805. JB Lippincott: Philadelphia
Llano, E., Pendas, A. M., Knäuper, V., Sorsa, T., Salo, T., Salido, E., Murphy, G., Simmer, J. P., Bartlett, J. D. & Lopez-Otin, C. (1997). Identification and structural and functional characterization of human enamelysin (MMP-20). Biochemistry 36: 15101–15108.
Lohi, J. & Keski-Oja, J. (1995). Calcium ionophores decrease pericellular gelatinolytic activity via inhibition of 92-kDa gelatinase expression and decrease of 72-kDa gelatinase activation. J Biol Chem 270: 17602–17609.
Lohi, J., Harvima, I. & Keski-Oja, J. (1992). Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J Cell Biochem 50: 337–349.
Lohi, J., Lehti, K., Westermarck, J., Kähäri, V-M & Keski-Oja, J. (1996). Regulation of membrane-type matrix metalloproteinase (MT-MMP) expression by growth factors and the phorbol ester PMA. Eur J Biochem 239: 239–247.
McDougall, J. R., Bani, M. R., Lin, Y., Rak, J. & Kerbel, R. S. (1995). The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res 55: 4174–4181.
Mimori, K., Shiraishi, T., Fujie, T., Baba, K., Haraguchi, M., Abe, R., Ueo, H. & Akiyoshi, T. (1997). Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76: 531–536.
Montgomery, A. M. P., De Clerck, Y. A., Langley, K. E., Reisfeld, R. A. & Mueller, B. M. (1993). Melanoma-mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 53: 693–700.
Mueller, B. M. (1996). Different roles for plasminogen activators and metalloproteinases in melanoma metastasis. Curr Top Microbiol Immunol 213: 65–80.
Murphy, G. & Knäuper, V. (1997). Relating matrix metalloproteinase structure to function: why the ‘hemopexin’ domain?. Matrix Biol 15: 511–518.
van den Oord, J. J., Paemen, L., Opdenakker, G. & Wolf-Peeters, C. D. (1997). Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151: 665–670.
Opdenakker, G., Ashino-Fuse, H., van Damme, J., Billiau, A. & de Somer, P. (1983). Effects of 12-O-tetradecanoylphorbol 13-acetate on the production of mRNAs for human tissue-type plasminogen activator. Eur J Biochem 131: 481–487.
Peebles, P. T., Trisch, T. & Papageorge, A. G. (1980). Isolation of four unusual pediatric solid tumor cell lines. Ped Res 12: 485
Pendas, A. M., Knäuper, V., Puente, X. S., Llano, E., Mattei, M. G., Apte, S., Murphy, G. & Lopez-Otin, C. (1997). Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution. J Biol Chem 272: 4281–4286.
Powe, D. G., Brough, J. L., Carter, G. I., Bailey, E. M., Stetler-Stevenson, W. G., Turner, D. R. & Hewitt, R. E. (1997). TIMP-3 mRNA expression is regionally increased in moderately and poorly differentiated colorectal adenocarcinoma. Br J Cancer 75: 1678–1683.
Saarialho-Kere, U. K., Chang, E. S., Welgus, H. G. & Parks, W. C. (1992). Distinct localization of collagenase and tissue inhibitor of metalloproteinases expression in wound healing associated with ulcerative pyogenic granuloma. J Clin Invest 90: 1952–1957.
Saarialho-Kere, U. K., Kovacs, S. O., Pentland, A. P., Olerud, J. E., Welgus, H. G. & Parks, W. C. (1993). Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 92: 2858–2866.
Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. & Seiki, M. (1994). A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature (Lond) 370: 61–65.
Stetler-Stevenson, W. G., Liotta, L. A. & Kleiner, D. E. Jr (1993). Extracellular matrix: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434–1441.
Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A. & Goldberg, G. I. (1995). Mechanism of cell surface activation of 72 kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase. J Biol Chem 270: 5331–5338.
Uria, J. A., Stahle-Bäckdahl, M., Seiki, M., Fueyo, A. & Lopez-Otin, C. (1997). Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 57: 4882–4888.
Valente, P., Fassina, G., Melchiori, A., Masiello, L., Cilli, M., Vacca, A., Onisto, M., Santi, L., Stetler-Stevenson, W. G. & Albini, A. (1998). TIMP-2 over-expression reduces invasion and angiogenesis and proptects B 16F10 melanoma cells from apoptosis. Int J Cancer 75: 246–253.
de Vries, T. J., Quax, P. H. A., Denijn, M., Verrijp, K. N., Verheijen, J. H., Verspaget, H. W., Weidle, U. H., Ruiter, D. J. & van Muijen, G. N. P. (1994). Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144: 70–81.
Väisänen, A., Tuominen, H., Kallioinen, M. & Turpeenniemi-Hujanen, T. (1996). Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 180: 283–289.
Yoshuji, H., Gomez, D. E. & Thorgeirsson, U. P. (1996). Enhanced RNA expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in human breast cancer. Int J Cancer 69: 131–134.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Airola, K., Karonen, T., Vaalamo, M. et al. Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer 80, 733–743 (1999). https://doi.org/10.1038/sj.bjc.6690417
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690417
Keywords
This article is cited by
-
Elastin-derived peptides enhance melanoma growth in vivo by upregulating the activation of Mcol-A (MMP-1) collagenase
British Journal of Cancer (2010)
-
MMP19 is upregulated during melanoma progression and increases invasion of melanoma cells
Modern Pathology (2010)
-
Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target
Cellular and Molecular Life Sciences (2010)
-
Stromal Collagenase in Melanoma: A Vascular Connection
Journal of Investigative Dermatology (2009)